LYEL Lyell Immunopharma, Inc.
8.560USD-0.58%Mkt Cap: 209.76M $P/E: —1d ago
Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company's lead product …
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.27BUSDP/E 30.7
$22.99BUSDP/E 14.5
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap209.76M USD
Enterprise Value53.49M USD
Revenue (TTM)27.00K USD
Gross Profit27.00K USD
Net Income (TTM)-274.45M USD
Revenue/Share0.0010 USD
Last Price8.560 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees161
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.36
PEG—
EV/EBITDA-0.30
EV/Revenue1980.94
P/S7814.42
P/B0.86
EPS (TTM)-12.19
EPS (Forward)-6.32
52W Range
8.3800% of range45.00
52W High45.00 USD
52W Low8.380 USD
Profitability
Gross Margin100.00%
Oper. Margin-1183425.00%
EBITDA Margin0.00%
Profit Margin-762355.56%
ROE-110.57%
ROA-80.71%
Growth
Revenue Growth-50.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-150.02M USD
CapEx (TTM)780.00K USD
FCF Margin-269663.44%
FCF Yield-34.71%
Net Debt-157.50M USD
Net Debt/EBITDA0.87
Balance Sheet
Debt/Equity0.21
Current Ratio5.36
Quick Ratio5.12
Book Value/Sh9.99 USD
Cash/Share8.33 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJun 2, 2025
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)37.88 USD
Upside (mean)+342.5%
Target Range12.00 USD – 49.00 USD
12.00+342.5% to mean49.00
# Analysts8
Ownership
Shares Out.24.51M
Float12.13M
Insiders37.31%
Institutions54.22%
Short Interest
Short Ratio10.3d
Short % Float5.66%
Short % Out.4.85%
Shares Short1.19M
Short (prev mo.)1.15M
Technical
SMA 5012.86 (-33.4%)
SMA 20018.86 (-54.6%)
Beta-0.03
S&P 52W Chg16.45%
Avg Vol (30d)129.59K
Avg Vol (10d)142.61K
Technical Indicators
RSI (14)21.7
MACD-1.2183
MACD Signal-1.0916
MACD Hist.-0.1266
BB Upper13.28 USD
BB Middle10.52 USD
BB Lower7.767 USD
BB Width52.39%
ATR (14)0.6845 USD
Vol Ratio (20d)1.29x